Abstract

Identifying febrile children at risk of sepsis in low-resource settings can improve survival, but recognition triage tools are lacking. Here we test the hypothesis that measuring circulating markers of immune and endothelial activation may identify children with sepsis at risk of all-cause mortality. In a prospective cohort study of 2,502 children in Uganda, we show that Soluble Triggering Receptor Expressed on Myeloid cells-1 (sTREM-1) measured at first clinical presentation, had high predictive accuracy for subsequent in-hospital mortality. sTREM-1 had the best performance, versus 10 other markers, with an AUROC for discriminating children at risk of death of 0.893 in derivation (95% CI 0.843–0.944) and 0.901 in validation (95% CI 0.856–0.947) cohort. sTREM-1 cutoffs corresponding to a negative likelihood ratio (LR) of 0.10 and a positive LR of 10 classified children into low (1,306 children, 53.1%), intermediate (942, 38.3%) and high (212, 8.6%) risk zones. The estimated incidence of death was 0.5%, 3.9%, and 31.8%, respectively, suggesting sTREM-1 could be used to risk-stratify febrile children. These findings do not attempt to derive a risk prediction model, but rather define sTREM-1 cutoffs as the basis for rapid triage test for all cause fever syndromes in children in low-resource settings.

Identification of febrile children at risk of death in low-resource settings can improve survival, but tools for their prompt recognition are lacking. Here, the authors show that sTREM-1 measured at clinical presentation predicts in-hospital mortality in febrile children in Uganda.

Details

Title
Risk-stratification of febrile African children at risk of sepsis using sTREM-1 as basis for a rapid triage test
Author
Leligdowicz Aleksandra 1   VIAFID ORCID Logo  ; Conroy, Andrea L 2   VIAFID ORCID Logo  ; Hawkes, Michael 3 ; Richard-Greenblatt, Melissa 4 ; Zhong, Kathleen 4 ; Opoka, Robert O 5 ; Namasopo Sophie 6 ; Bell, David 7   VIAFID ORCID Logo  ; Conrad, Liles W 8 ; da Costa Bruno R 9 ; Jüni, Peter 9 ; Kain, Kevin C 10   VIAFID ORCID Logo 

 Robarts Research Institute, University of Western Ontario, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884) 
 Indiana University School of Medicine, Department of Pediatrics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919) 
 3-593 Edmonton Clinic Health Academy, University of Alberta, Division of Pediatric Infectious Diseases, Edmonton, Canada (GRID:grid.17089.37) 
 Toronto General Hospital, University Health Network, Sandra Rotman Centre for Global Health, MaRS Centre, Toronto, Canada (GRID:grid.417184.f) (ISNI:0000 0001 0661 1177) 
 Mulago Hospital and Makerere University, Department of Paediatrics and Child Health, Kampala, Uganda (GRID:grid.416252.6) (ISNI:0000 0000 9634 2734) 
 Kabale District Hospital, Department of Pediatrics, Kabale, Uganda (GRID:grid.416252.6) 
 Independent consultant, Issaquah, USA (GRID:grid.416252.6) 
 Global Health, and Pharmacology, 1959 NE Pacific Street; HSB RR-511, Box 356420, University of Washington, Departments of Medicine, Pathology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael’s Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada (GRID:grid.415502.7) 
10  Tropical Disease Unit, Sandra Rotman Centre for Global Health, Toronto General Hospital, University Health Network, Department of Medicine, University of Toronto, MaRS Centre, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2602346011
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.